Early Phase II Clinical Study of TS-142 in Patients with Insomnia
Phase 2
Completed
- Conditions
- Insomnia
- Registration Number
- JPRN-jRCT2080223515
- Lead Sponsor
- Taisho Pharmaceutical co., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Diagnosis of insomnia disorder
- Outpatient
etc.
Exclusion Criteria
- Any lifetime diagnosis of others Sleep-Wake Disorder.
- Serious hepatic disorder, renal disorder.
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy<br>latency to persistent sleep and wakefulness after sleep once by polysomnography(PSG)
- Secondary Outcome Measures
Name Time Method efficacy<br>Total Sleep Time by polysomnography